Skip to search formSkip to main contentSkip to account menu

Hepatitis B Vaccines

Known as: Hepatitis B Vaccines [Chemical/Ingredient], Vaccines, Hepatitis B, Hepatitis B vaccine 
Vaccines or candidate vaccines containing inactivated hepatitis B or some of its component antigens and designed to prevent hepatitis B. Some… 
National Institutes of Health

Related topics

Related topics

30 relations

Narrower (22)

Betagen VaccineCOMVAXEngerix-BEuvax-B
Hepatitis B Surface AntigensIn BloodProcess of secretionagonists

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
Newborn hepatitis B vaccination coverage among children born January 2003-June 2005--United States.
  • MMWR. Morbidity and mortality weekly report
  • 2008
  • Corpus ID: 7793864
Hepatitis B vaccine was first recommended for administration to all infants in 1991 by the Advisory Committee on Immunization… 
2008
2008
[Active immunization against hepatitis B].
The efficacy of the hepatitis B vaccine Hevac B Pasteur was assessed in 277 persons over a period of 6 months. HBs antigen of 5… 
Review
1999
Review
1999
Long-term effectiveness of infancy low-dose hepatitis B vaccine immunization in Zhuang minority area in China.
AIM:To observe the long-term effectiveness of low-dose immunization strategy and risk factors of HBsAg carriers in immunized… 
1998
1998
Persistence of hepatitis B vaccine immune protection and response to hepatitis B booster immunization.
AIM:To identify the persistence of immune protection of China-made, plasma derived hepatitis B vaccine after infancy immunization… 
1994
1994
Clinical Trial of a PreS2-containing Recombinant Hepatitis B Vaccine
Conventional hepatitis B vaccines have met with three problems: escape mutants, delayed anti-HBs response, and nonresponders. We… 
1990
1990
Immunogenicity of hepatitis B vaccine (HEVAC B) in children with advanced renal failure
The immune response after hepatitis B (HB) vaccine HEVAC B was studied in 33 children (mean age 10±4 years) with advanced renal… 
1987
1987
Discussion of Hepatitis B Vaccine: Prospects for Duration of Immunity
When Al Evans started exploring the hepatitis field almost forty years ago, he had to do so with the techniques of the time. In… 
1987
1987
Immunogenicity of a yeast-derived hepatitis B vaccine (Engerix-B) in healthy young adults.
In a study comparing the safety and immunogenicity of a recombinant DNA yeast-derived hepatitis B vaccine with that of a plasma… 
1984
1984
Immunogenicity and safety of a plasma-derived heat-inactivated hepatitis B vaccine (CLB). Studies in volunteers at a low risk of infection with hepatitis B virus.
The safety and immunogenicity of a plasma-derived heat-inactivated hepatitis B vaccine (CLB) were evaluated in 471 healthy human… 
1984
1984
World-wide control of hepatitis B.
It has been 30 years since the Third World Health Assembly convened a WHO Expert Committee to consider investigation, control…